This may be because that the phosphorylation of STAT3 was at a low level in vitro, while the complex tumor microenvironment such as the possible presence of exogenous polyunsaturated fatty acids and exosomes upregulated STAT3 in tumor cells, making the inhibitory effect of iruplinalkib more pronounced [50, 51]. Here, STAT3 is linked to neoplasm.